Disrupted gut microecology after high-dose 131 I therapy and radioprotective effects of arachidonic acid supplementation.

These findings highlight that ARA, as a key metabolite, substantially contributes to radioprotection. Our study provides novel insights into the pivotal role that the microbiota-metabolite axis plays in radionuclide protection and offers effective biological targets for treating radiation-induced adverse effects.